CHRS
Coherus BioSciences Inc
NASDAQ: CHRS · HEALTHCARE · BIOTECHNOLOGY
$1.74
-1.69% today
Updated 2026-04-29
Market cap
$262.31M
P/E ratio
—
P/S ratio
6.22x
EPS (TTM)
$-1.56
Dividend yield
—
52W range
$1 – $3
Volume
1.3M
Coherus BioSciences Inc (CHRS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.25M | $15.42M | $-23.93M | $-107.99M | $-252.54M | $-200.29M | $-159.27M | $28.36M | $154.15M | $-37.43M | $-241.12M | $-174.88M | $-20.44M | $-138.51M |
| Capital expenditures | $1.78M | $373000.00 | $2.85M | $6.16M | $6.51M | $4.57M | $789000.00 | $12.90M | $7.23M | $1.29M | $2.04M | $286000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $443000.00 | $2.04M | $11.06M | $16.72M | $27.42M | $36.06M | $34.80M | $33.59M | $38.16M | $51.36M | $50.74M | $43.11M | $27.80M | $16.97M |
| Free cash flow | $-20.03M | $15.05M | $-26.78M | $-114.15M | $-259.06M | $-204.86M | $-160.06M | $15.46M | $146.91M | $-38.72M | $-243.16M | $-175.17M | $-20.44M | $-138.51M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $72.14M | $20.35M | $1.75M | $3.74M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $110.84M | $7.83M | $-33.28M | $1.96M | $-55.03M | $104.99M | $363.69M | $-123.96M | $-353.65M | — | — | — |